Pyxis Oncology (PYXS) stock: insider trades, news & valuation
Health Care · Net sellingShare price and insider trades
Pyxis Oncology insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $123K of PYXS stock on the open market.
Get emailed when insiders cluster-buy stocks like PYXS
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PYXS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $107K | 1 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | — | 0 |
| Q3 2025 | — | 0 | — | 0 |
| Q2 2025 | — | 0 | $16K | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Pyxis Oncology, Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $123K. 4 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
PYXS stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Gordonmd Global Investments Lp10% Owner | Buy | 5,517,00015,541,909 held (+55%) | — | $0 | — | — |
| Jul 2SEC | Jakob DupontDirector | Sell Plan | 35,00038,741 held (−47%) | $3.06 | $107K | -33.7% | — |
| Mar 25SEC | Rachel HumphreyDirector | Sell Plan | 13,89681,309 held (−15%) | $1.03 | $14K | +97.1% | — |
| Mar 25SEC | Rachel HumphreyDirector | Sell Plan | 1,40095,405 held (−1%) | $0.97 | $1K | +109.3% | — |
| Mar 25SEC | Rachel HumphreyDirector | Sell Plan | 20095,205 held (−0%) | $0.97 | $194 | +109.3% | — |
Insiders at Pyxis Oncology, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Jakob DupontDirector | — | $107K | Jul 2, 2026 | — |
| Rachel HumphreyDirector | — | $16K | Mar 25, 2026 | — |
| Gordonmd Global Investments Lp10% Owner | — | — | Oct 2, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
PYXS stock: common questions
Are Pyxis Oncology, Inc. insiders buying PYXS stock?
In the past 12 months, 0 insiders reported open-market purchases of PYXS worth $0. The latest was 10% Owner Gordonmd Global Investments Lp bought $0 of PYXS — raises the stake by 55%.
Are Pyxis Oncology, Inc. insiders selling PYXS stock?
2 insiders reported sales worth $123K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PYXS's 52-week range?
Over the past year PYXS has traded between $1.06 and $5.34. It last closed at $2.03 on Oct 9, 2026.